November 23, 2012 9:10 am by David Johnson, | 0 Comments
Bank of America reiterated its Buy rating and $43 price objective on St Jude Medical (NYSE: STJ) as it updated its stance on shares based on Durata.Bank of America said, ...
Read more
Cantor Fitzgerald initiated its coverage on CVS Caremark Corporation (NYSE: CVS) with a Buy rating and a $55 price target per share.Cantor Fitzgerald commented, "After several transition years, we look ...
Read more
Stifel Nicolaus reiterated its Buy rating on Zogenix (NASDAQ: ZGNX) but lowered its price target from $7 to $6.Stifel Nicolaus commented, "We look to Zohydro to be the true value ...
Read more
Jefferies lowered its rating on Aveo Pharmaceuticals (NASDAQ: AVEO) from Buy to Hold and reduced its price target from $30 to $11.Jefferies said, "The critical new disclosure from AVEO's 2Q ...
Read more
